Vancomycin- and erythromycin-induced hearing loss in humans
- 1 June 1989
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (6), 791-796
- https://doi.org/10.1128/aac.33.6.791
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Bilateral sensorineural hearing loss associated with mycoplasma pneumoniae infectionThe Laryngoscope, 1987
- Irreversible Ototoxic Effect of ErythromycinScandinavian Audiology, 1986
- Vancomycin: a reappraisal.BMJ, 1982
- The Ototoxic Interaction of Viomycin, Capreomycin and Polymyxin B With Ethacrynic AcidActa Oto-Laryngologica, 1982
- Comparative Ototoxicity of Bumetanide and Furosemide when Used in Combination with KanamycinThe Journal of Clinical Pharmacology, 1981
- Ototoxicity of Erythromycin in Patients with Renal InsufficiencyNew England Journal of Medicine, 1979
- Vancomycin. A second lookPublished by American Medical Association (AMA) ,1977
- Prevention of Staphylococcal shunt infections by continuous vancomycin prophylaxisThe American Journal of the Medical Sciences, 1971
- Kanamycin Ototoxicity—Possible Potentiation by Other DrugsSouthern Medical Journal, 1970
- Vancomycin: Report on Treatment of Patients with Severe Staphylococcal InfectionsBMJ, 1959